|
Aug. 09, 2022 |
|
|
Oct. 15, 2024 |
|
|
jRCT1030220258 |
Observational Study to Investigate the Recognition Gap between Patients and Physicians In Neurological Diseases (Parkinson's disease, multiple sclerosis, epilepsy) and Development of a Predictive Model Using AI (GAP-AI) (GAP-AI) |
|
Patients-Physicians Gap Survey (GAP-AI) |
|
Aug. 30, 2024 |
|
198 |
|
Of the patients, 119 were women (60.0%) and 104 were at least 60 years of age (52.8%). The most common diagnosis was Parkinson's disease (69.5%), followed by multiple sclerosis (20.3%) and epilepsy (10.2%), with an overall mean disease duration of 7.4 years. |
|
In total, 198 patients were enrolled and 197 patients were included in the FAS (one patient withdrew their consent). |
|
No reports of adverse events |
|
Slight gaps in perceptions between patients and physicians were identified regarding the primary endpoints of patient satisfaction, shared decision-making, activities of daily living, and quality of life. |
|
This study identified perception gaps between patients with neurological diseases and their physicians and the factors that influence them. Multiple machine learning algorithms were used to develop predictive models based on study data. Insights from this study underscore the importance of recognizing such discrepancies for enhancing clinical practice through a better understanding between patients and their physicians. |
No |
|
We provide access to the de-identified individual participant data (IPD) for eligible studies to aid qualified researchers in addressing legitimate scientific objectives. These IPDs will be provided in a secure research environment following approval of a data sharing request, and under the terms of a data sharing agreement. |
|
https://jrct.mhlw.go.jp/latest-detail/jRCT1030220258 |
Oyama Genko |
||
Juntendo University Hospital |
||
3-1-1 Hongo,Bunkyo-ku, Tokyo |
||
+81-3-3813-3111 |
||
g_oyama@juntendo.ac.jp |
||
Oyama Genko |
||
Juntendo University Hospital |
||
3-1-1 Hongo,Bunkyo-ku, Tokyo |
||
+81-3-3813-3111 |
||
g_oyama@juntendo.ac.jp |
Complete |
Sept. 01, 2022 |
||
| 200 | ||
Observational |
||
1. Diagnosis of target disease: Parkinson's disease, multiple sclerosis, epilepsy (Juvenile myoclonic epilepsy, juvenile absence-like epilepsy, grand mal epilepsy in wakefulness) |
||
1. Patients aged < 18 years at the time of informed consent |
||
| 18age old over | ||
| No limit | ||
Both |
||
Parkinson's disease, Multiple sclerosis, Epilepsy |
||
The primary endpoint will be the results of the following questionnaire, which will be assessed by both patients and physicians in pairs, in order to clarify the actual situation of the three gaps in the level of understanding of the patient's condition, the level of satisfaction, and the SDM between patients with neurological diseases (Particularly outpatients with Parkinson's disease, multiple sclerosis, or epilepsy) and physicians. |
||
As a secondary objective, in order to clarify the factors affecting the gap in the level of understanding of the patient's condition, the level of satisfaction, and SDM between patients with neurological diseases (Particularly outpatients with Parkinson's disease, multiple sclerosis, or epilepsy) and attending physicians, which was revealed in the primary endpoint, the results of the questionnaire to be answered by only the following patients, physician's attribute information, and necessary items in EMRs will be tabulated and analyzed as secondary endpoints. |
||
| Juntendo University Hospital |
| Takeda Pharmaceutical Company Limited | |
| Applicable |
| Medical Department Ethics Committee, Juntendo University | |
| 3-1-3 Hongo,Bunkyo-ku, Tokyo, Tokyo | |
+81-3-3818-3111 |
|
| hongo-rinri@juntendo.ac.jp | |
| Approval | |
July. 08, 2022 |
none |